Raghav Sehgal, PhD, is an associate research scientist in computational biology at Yale University and a scientific principal at Longevity Tech Fund, a venture capital firm that focuses on investing in companies that are innovating in the fields of AI, digital health, medical devices, and diagnostics. Dr. Sehgal is passionate about solving the mysteries of aging and extending healthy lifespans. He is developing machine learning and deep learning tools to analyze multi-omic and multi-modal data, and to answer questions about what biological systems drive aging, how we can measure them, and if we can reverse them. As part of his research, he built SYMPHONYAge a patented biomarker that can measure aging in 11 different organs from a single blood draw.

At Longevity Tech Fund, Dr. Sehgal provides expert advice on potential investment opportunities and helped raise their second fund by building strategies for future investments. He has 10 years of experience in applying data science and AI to the biomedical space as a scientist, engineer, product manager, team builder, academician, and entrepreneur. He completed his PhD at Yale University, is a Forbes 30 Under 30 honoree, and has received awards such as the Gruber Science Fellowship and Impetus Aging Grant.

‍